Kalamazoo Forward Ventures

CircNova is a biotechnology company focused on the development of therapies targeting non-coding RNA, particularly circular RNA, to address challenging disease targets that are often considered undruggable. By leveraging artificial intelligence, CircNova generates, analyzes, and identifies circular RNA sequences, enabling innovative approaches to therapeutic development. The company's research aims to unlock new mechanisms of action and potential treatments for a variety of diseases, positioning CircNova at the forefront of biotechnological advancements in RNA therapeutics.

Glidance is a company focused on developing a self-driving mobility aid specifically designed for individuals with sight loss. By harnessing advancements in robotics, artificial intelligence, and autonomous systems, Glidance aims to enhance independent mobility for the visually impaired. The technology enables users to navigate their surroundings safely and efficiently, allowing them to maneuver through crowded spaces and around obstacles with confidence. This innovative platform not only facilitates navigation to various destinations, such as doors, stairwells, or park seats, but also empowers individuals with disabilities to experience greater autonomy in their daily lives.